Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03IJO
|
|||
| Former ID |
DNCL003458
|
|||
| Drug Name |
GS-9820
|
|||
| Indication | Chronic lymphocytic leukaemia [ICD-11: 2A82.0; ICD-10: C83.0, C91.1] | Phase 1 | [1] | |
| Lymphoma [ICD-11: 2A80-2A86] | Phase 1 | [1] | ||
| Company |
Gilead Sciences
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H16FN7O
|
|||
| Canonical SMILES |
CC(C1=NC2=C(C=C(C=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5
|
|||
| InChI |
1S/C21H16FN7O/c1-12(27-19-17-18(24-10-23-17)25-11-26-19)20-28-16-8-7-13(22)9-15(16)21(30)29(20)14-5-3-2-4-6-14/h2-12H,1H3,(H2,23,24,25,26,27)/t12-/m0/s1
|
|||
| InChIKey |
DOCINCLJNAXZQF-LBPRGKRZSA-N
|
|||
| CAS Number |
CAS 870281-34-8
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Gilead. | |||
| REF 2 | National Cancer Institute Drug Dictionary (drug id 741949). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.